Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study

To retrospectively analyze the treatment status of tyrosine kinase inhibitors (TKI) in newly diagnosed patients with chronic myeloid leukemia (CML) in China. Data of chronic phase (CP) and accelerated phase (AP) CML patients diagnosed from January 2006 to December 2022 from 77 centers, ≥18 years old...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Zhōnghuá xuèyèxué zázhì 2024-03, Vol.45 (3), p.215
Hauptverfasser:	Zhang, X S, Liu, B C, Du, X, Zhang, Y L, Xu, N, Liu, X L, Li, W M, Lin, H, Liang, R, Chen, C Y, Huang, J, Yang, Y F, Zhu, H L, Pan, L, Wang, X D, Li, G H, Liu, Z G, Zhang, Y Q, Liu, Z F, Hu, J D, Liu, C S, Li, F, Yang, W, Meng, L, Han, Y Q, Lin, L E, Zhao, Z Y, Tu, C Q, Zheng, C F, Bai, Y L, Zhou, Z P, Chen, S N, Qiu, H Y, Yang, L J, Sun, X L, Sun, H, Zhou, L, Liu, Z L, Wang, D Y, Guo, J X, Pang, L P, Zeng, Q S, Suo, X H, Zhang, W H, Zheng, Y J, Jiang, Q
Format:	Artikel
Sprache:	chi
Schlagworte:	Adult China Dasatinib - therapeutic use Female Humans Imatinib Mesylate - therapeutic use Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Male Middle Aged Pyrimidines - therapeutic use Retrospective Studies Treatment Outcome Tyrosine Kinase Inhibitors - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!